TGFB1 and inflammatory breast carcinoma: Seven IBC cases (35%) had deleterious germline SNVs in either SMAD4 or USP9X, both involved in TGFβ signaling; one of these cases had variants in both the coding and non-coding regions and the rest of cases only had non-coding variants (Additional file 7: Table S6).